April 24, 2026 10:00 AM EDTUpdated 11 hours ago Cell/Gene TxIn FocusGLP-1 drugs Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapy Ryan Cross Senior Science Correspondent The new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
endpoints· 2mo ago
saveExclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapy
April 24, 2026read original ↗
The new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies suggest most of those who start taking GLP-1 drugs quit ...
91 words · extracted 2mo agoread original ↗
🔗 mentioned in this article
related news
- Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelicsbiopharma dive · 2mo ago · 2 shared entities
- STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and morestat · 2mo ago · 2 shared entities
- Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugsstat · 2mo ago · 1 shared entity
- STAT+: Up and down the ladder: The latest comings and goingsstat · 2mo ago · 1 shared entity
- International childhood vaccine campaign growsstat · 2mo ago · 1 shared entity
comments(0)
5-min edit window · permanent after that